Oncogenic targeting of BRM drives malignancy through C/EBP?-dependent induction of ?5 integrin.
Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM. Oncogenic targeting of BRM drives malignancy through C/EBP?-dependent induction of ?5 integrin. Oncogene. 2014 May 08; 33(19):2441-53.